Loeb & Loeb LLP

Loeb & Loeb LLP advises pharma, biotech, and medical devices companies on IP, transactional, and regulatory matters. The firm helps clients secure and sustain capital for product development and market entry through counsel on financing, M&A, and public offerings, also supporting related regulatory and IP issues. New York-based co-chair Kathleen Gersh, an IP lawyer, specializes in Hatch-Waxman litigation, counseling, and related FDA regulatory strategies. She plays a key role in the firm’s IP offering, which also includes due diligence and collaboration agreements. The team also advises on FDA regulatory strategy and compliance, with Washington DC-based co-chair Jim Czaban providing counsel on these matters, as well as federal and state enforcement actions.